![Gadolinium / Nephrogenic systemic fibrosis / Magnetic resonance imaging / Radiocontrast agent / Ketorolac / Lorazepam / MRI contrast agent / Cardiac MRI perfusion / Chemistry / Matter / Gadodiamide Gadolinium / Nephrogenic systemic fibrosis / Magnetic resonance imaging / Radiocontrast agent / Ketorolac / Lorazepam / MRI contrast agent / Cardiac MRI perfusion / Chemistry / Matter / Gadodiamide](https://www.pdfsearch.io/img/076a5ea565f1d41853b7c22347eafcc1.jpg) Date: 2013-10-18 16:38:58Gadolinium Nephrogenic systemic fibrosis Magnetic resonance imaging Radiocontrast agent Ketorolac Lorazepam MRI contrast agent Cardiac MRI perfusion Chemistry Matter Gadodiamide | | The recommended dose of Gadavist is 0.1 mL/kg body weight (0.1 mmol/kg), administered as an intravenous bolus injection at a flow rate of approximately 2 mL/second. Flush the intravenous cannula with physiological salineAdd to Reading ListSource URL: www.accessdata.fda.govDownload Document from Source Website File Size: 731,83 KBShare Document on Facebook
|